Event
Fierce Biotech Week
October 7 - October 9, 2025
Boston, Mass.
Fierce Biotech Week brings together the brightest minds in drug development, clinical research, business development & licensing, TMF, and communications to advance innovation and shape biotech’s future. Get ready to spark new partnerships, accelerate breakthroughs, and lead in this dynamic and rapidly evolving industry.
Fierce Biotech Week features insights from C-suite and executive leadership at biotech, mid-sized and large pharma companies on emerging trends and market dynamics that will help effectively prioritize R&D spend, optimize drug development and clinical operations, mitigate the risks associated with capital raising, and unlock the potential of a joint venture, licensing or M&A deal.
Attendees – 1,100+ (700 Biotech) C-suite and executive leadership at biotech, mid-sized and large pharma companies expected to share strategies, address industry challenges, and drive innovation in drug development and clinical research through collaborative insights and expert leadership.
Schedule a meeting to talk to our team!
Sheela Hegde
Managing Partner & Global Head, Health Advances
Tuesday, October 7, from 2 – 2:30p.m.
Title – Optimizing the clinical research workforce of the future
From innovative trial designs and novel drug modalities to the explosive growth of data and the rise of Artificial Intelligence (AI), drug development has become more complex. Remaining in front of these emerging trends and industry changes requires a new level of agility and innovative problem solving, necessitating the transformation of the biopharmaceutical industry workforce. But are pharmaceutical and biotech companies – and CROs, ready to embrace these changes? And is the workforce we have in place today equipped to meet these shifting needs of clinical development?
To answer these questions, Parexel spearheaded a biopharmaceutical industry analysis that benchmarked the trends impacting the clinical research workforce. The analysis identified the actionable steps necessary to foster a strong talent pool, instill positive culture, and optimize resource delivery model to help drug sponsors bring life-changing treatments to patients faster.
Our fireside chat will review the findings of this research, along with insights from leaders sharing what they are hearing from industry.
Judith Millard
Vice President, Enterprise Account Leader
Tuesday, October 7, from 2 – 2:30p.m.
Title – Optimizing the clinical research workforce of the future
From innovative trial designs and novel drug modalities to the explosive growth of data and the rise of Artificial Intelligence (AI), drug development has become more complex. Remaining in front of these emerging trends and industry changes requires a new level of agility and innovative problem solving, necessitating the transformation of the biopharmaceutical industry workforce. But are pharmaceutical and biotech companies – and CROs, ready to embrace these changes? And is the workforce we have in place today equipped to meet these shifting needs of clinical development?
To answer these questions, Parexel spearheaded a biopharmaceutical industry analysis that benchmarked the trends impacting the clinical research workforce. The analysis identified the actionable steps necessary to foster a strong talent pool, instill positive culture, and optimize resource delivery model to help drug sponsors bring life-changing treatments to patients faster.
Our fireside chat will review the findings of this research, along with insights from leaders sharing what they are hearing from industry.
Request a meeting
Are you interested in meeting with our experts at this event? Please fill out the form below, and we'll contact you with more details.